Long-term and Low-Dose of Busulfan is a Safe and Effective Second-Line Treatment in Elderly Patients with Essential Thrombocythemia Resistant or Intolerant to Hydroxyurea
Blood cancer journal（2018）
Hematology Division and Bone Marrow Unit
Key words
Chemotherapy,Myeloproliferative disease,Biomedicine,general,Cancer Research,Oncology,Hematology
PDF
View via Publisher
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Related Papers
Polycythemia Vera: 2024 Update on Diagnosis, Risk-Stratification, and Management
AMERICAN JOURNAL OF HEMATOLOGY 2023
被引用22
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn
Chat Paper
Summary is being generated by the instructions you defined